| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Royalty Pharma plc | $50.69 | 0.5% | $21.72B | 28.2 | -42.9% | 1.3% | Healthcare | 57.9% | 7.8% | ||
| 2 | Ligand Pharmaceuticals Incorporated | $232.55 | 0.1% | $4.57B | -1057.0 | -17.5% | — | Healthcare | 125.1% | 64.8% | ||
| 3 | Innoviva, Inc. | $22.52 | -0.6% | $1.91B | 6.8 | 683.1% | — | Healthcare | 20.4% | 13.6% | ||
| 4 | BlackRock Technology and Private Equity Term Trust | $8.18 | 0.5% | $955M | 48.1 | — | 10.5% | Healthcare | 28.2% | — | ||
| 5 | Cibus, Inc. | $1.59 | 3.2% | $728M | -0.6 | 67.8% | — | Healthcare | -23.2% | -14.6% | ||
| 6 | XOMA Royalty Corp. | $41.60 | -0.1% | $493M | 28.5 | 189% | 0.7% | Healthcare | 80.6% | 126.2% | ||
| 7 | XOMA Corporation | $25.32 | -0.3% | $306M | 17.3 | 344.4% | 1.2% | Healthcare | -1.5% | 83.1% | ||
| 8 | CDT Equity Inc. | $2.26 | 8.7% | $399656 | 0.0 | 103.5% | — | Healthcare | -99.8% | — |